Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death
- PMID: 22086876
- PMCID: PMC4365497
- DOI: 10.1161/CIRCULATIONAHA.111.050666
Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death
Abstract
Background: The molecular pathways that regulate the extent of ischemic injury and post-myocardial infarction (MI) remodeling are not well understood. We recently demonstrated that glycogen synthase kinase-3α (GSK-3α) is critical to the heart's response to pressure overload. However, the role, if any, of GSK-3α in regulating ischemic injury and its consequences is not known.
Methods and results: MI was induced in wild-type (WT) versus GSK-3α((-/-)) (KO) littermates by left anterior descending coronary artery ligation. Pre-MI, WT, and KO hearts had comparable chamber dimensions and ventricular function, but as early as 1 week post-MI, KO mice had significantly more left ventricular dilatation and dysfunction than WT mice. KO mice also had increased mortality during the first 10 days post-MI (43% versus 22%; P=0.04), and postmortem examination confirmed cardiac rupture as the cause of most of the deaths. In the mice that survived the first 10 days, left ventricular dilatation and dysfunction remained worse in the KO mice throughout the study (8 weeks). Hypertrophy, fibrosis, and heart failure were all increased in the KO mice. Given the early deaths due to rupture and the significant reduction in left ventricular function evident as early as 1 week post-MI, we examined infarct size following a 48-hour coronary artery ligation and found it to be increased in the KO mice. This was accompanied by increased apoptosis in the border zone of the MI. This increased susceptibility to ischemic injury-induced apoptosis was also seen in cardiomyocytes isolated from the KO mice that were exposed to hypoxia. Finally, Bax translocation to the mitochondria and cytochrome C release into the cytosol were increased in the KO mice.
Conclusion: GSK-3α confers resistance to ischemic injury, at least in part, via limiting apoptosis. Loss of GSK-3α promotes ischemic injury, increases risk of cardiac rupture, accentuates post-MI remodeling and left ventricular dysfunction, and increases the progression to heart failure. These findings are in striking contrast to multiple previous reports in which deletion or inhibition of GSK-3β is protective.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4365497/bin/nihms-666451-f0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4365497/bin/nihms-666451-f0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4365497/bin/nihms-666451-f0003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4365497/bin/nihms-666451-f0004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4365497/bin/nihms-666451-f0005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4365497/bin/nihms-666451-f0006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4365497/bin/nihms-666451-f0007.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4365497/bin/nihms-666451-f0008.gif)
Similar articles
-
Cardiac fibroblast GSK-3α aggravates ischemic cardiac injury by promoting fibrosis, inflammation, and impairing angiogenesis.Basic Res Cardiol. 2023 Sep 1;118(1):35. doi: 10.1007/s00395-023-01005-1. Basic Res Cardiol. 2023. PMID: 37656238
-
Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure.J Am Coll Cardiol. 2014 Aug 19;64(7):696-706. doi: 10.1016/j.jacc.2014.04.068. J Am Coll Cardiol. 2014. PMID: 25125302 Free PMC article.
-
Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.Circ Res. 2010 May 28;106(10):1635-45. doi: 10.1161/CIRCRESAHA.109.211482. Epub 2010 Apr 1. Circ Res. 2010. PMID: 20360256 Free PMC article.
-
Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure.Curr Drug Targets. 2021;22(13):1568-1576. doi: 10.2174/1389450122666210224105430. Curr Drug Targets. 2021. PMID: 33655828 Review.
-
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.Dan Med Bull. 2001 Nov;48(4):199-210. Dan Med Bull. 2001. PMID: 11767125 Review.
Cited by
-
Mitochondrial Kinase Signaling for Cardioprotection.Int J Mol Sci. 2024 Apr 19;25(8):4491. doi: 10.3390/ijms25084491. Int J Mol Sci. 2024. PMID: 38674076 Free PMC article. Review.
-
Zonisamide attenuates pressure overload-induced myocardial hypertrophy in mice through proteasome inhibition.Acta Pharmacol Sin. 2024 Apr;45(4):738-750. doi: 10.1038/s41401-023-01191-7. Epub 2023 Dec 14. Acta Pharmacol Sin. 2024. PMID: 38097716
-
Mechanistic Implications of GSK and CREB Crosstalk in Ischemia Injury.Neurotox Res. 2023 Dec 13;42(1):1. doi: 10.1007/s12640-023-00680-1. Neurotox Res. 2023. PMID: 38091155 Review.
-
Cardiac fibroblast GSK-3α aggravates ischemic cardiac injury by promoting fibrosis, inflammation, and impairing angiogenesis.Basic Res Cardiol. 2023 Sep 1;118(1):35. doi: 10.1007/s00395-023-01005-1. Basic Res Cardiol. 2023. PMID: 37656238
-
Novel GSK-3β Inhibitor Neopetroside A Protects Against Murine Myocardial Ischemia/Reperfusion Injury.JACC Basic Transl Sci. 2022 Sep 28;7(11):1102-1116. doi: 10.1016/j.jacbts.2022.05.004. eCollection 2022 Nov. JACC Basic Transl Sci. 2022. PMID: 36687267 Free PMC article.
References
-
- Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101:2981–2988. - PubMed
-
- Gajarsa JJ, Kloner RA. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev. 2011;16:13–21. - PubMed
-
- Vigneron F, Dos Santos P, Lemoine S, Bonnet M, Tariosse L, Couffinhal T, Duplaa C, Jaspard-Vinassa B. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways. Cardiovasc Res. 2011;90:49–56. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials